We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+5%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.3B
AUM Growth
+$535M
(+1.3%)
Cap. Flow
-$468M
Cap. Flow
% of AUM
-1.16%
Top 10 Holdings %
Top 10 Hldgs %
15.78%
Holding
2,279
New
170
Increased
711
Reduced
1,071
Closed
189
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$178M |
| 2 |
LyondellBasell Industries
LYB
|
+$133M |
| 3 |
AT&T
T
|
+$124M |
| 4 |
Stanley Black & Decker
SWK
|
+$101M |
| 5 |
Pfizer
PFE
|
+$93.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$229M |
| 2 |
Gilead Sciences
GILD
|
+$164M |
| 3 |
Broadcom
AVGO
|
+$149M |
| 4 |
KeyCorp
KEY
|
+$145M |
| 5 |
Darden Restaurants
DRI
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.22% |
| 2 | Technology | 14.47% |
| 3 | Financials | 10.84% |
| 4 | Industrials | 9.01% |
| 5 | Consumer Discretionary | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
United Bankshares
UBSI
$6.44B
| $2.29M | 0.01% |
77,262
-23,514
| -23% | -$740K |
|
|
TVRD
902
Tvardi Therapeutics
TVRD
$23.1M
| $2.29M | 0.01% |
22,498
+17,377
| +339% | +$2.39M |
|
|
HAPN
903
Happen Inc
HAPN
$1.88B
| $2.29M | 0.01% |
234,980
-102,196
| -30% | -$821K |
|
|
RCM
904
DELISTED
R1 RCM Inc. Common Stock
RCM
| $2.28M | 0.01% |
123,662
+21,948
| +22% | +$357K |
|
|
NATI
905
DELISTED
National Instruments Corp
NATI
| $2.28M | 0.01% |
39,717
-3,256
| -8% | -$187K |
|
|
AVTA
906
DELISTED
Avantax, Inc. Common Stock
AVTA
| $2.26M | 0.01% |
101,159
-25,212
| -20% | -$594K |
|
907
Chemours
CC
$2.17B
| $2.24M | 0.01% |
60,761
+10,678
| +21% | +$326K |
|
|
SPTN
908
DELISTED
SpartanNash
SPTN
| $2.24M | 0.01% |
99,502
-29,201
| -23% | -$684K |
|
|
UCTT
909
Ultra Clean Holdings
UCTT
$3.01B
| $2.24M | 0.01% |
58,199
-11,502
| -17% | -$370K |
|
910
Ceco Environmental
CECO
$4.07B
| $2.23M | 0.01% |
167,066
| – | – |
|
911
Acuity Brands
AYI
$8.89B
| $2.2M | 0.01% |
13,499
-173
| -1% | -$27.6K |
|
912
Collegium Pharmaceutical
COLL
$722M
| $2.2M | 0.01% |
102,393
+29,223
| +40% | +$663K |
|
|
UNIT
913
Uniti Group
UNIT
$2.32B
| $2.2M | 0.01% |
476,158
+274,223
| +136% | +$1.03M |
|
|
MRC
914
DELISTED
MRC Global
MRC
| $2.2M | 0.01% |
218,426
-339,514
| -61% | -$3.21M |
|
915
Pricesmart
PSMT
$5.15B
| $2.19M | 0.01% |
29,593
-22
| -0.1% | -$1.62K |
|
916
Mondelez International
MDLZ
$79.6B
| $2.18M | 0.01% |
29,950
+2,311
| +8% | +$171K |
|
|
CNH
917
CNH Industrial
CNH
$21.7B
| $2.17M | 0.01% |
150,725
| – | – |
|
918
AppFolio
APPF
$7.83B
| $2.16M | 0.01% |
12,558
+11,829
| +1,623% | +$1.72M |
|
|
IPG
919
DELISTED
Interpublic Group of Companies
IPG
| $2.15M | 0.01% |
55,822
+2,800
| +5% | +$106K |
|
|
HTB
920
HomeTrust Bancshares
HTB
$772M
| $2.15M | 0.01% |
103,045
-1,185
| -1% | -$25.2K |
|
921
Occidental Petroleum
OXY
$59.3B
| $2.15M | 0.01% |
36,591
-32,148
| -47% | -$1.93M |
|
922
Vistra
VST
$47.1B
| $2.14M | 0.01% |
81,578
+13,309
| +19% | +$325K |
|
923
Teck Resources
TECK
$31.5B
| $2.13M | 0.01% |
+50,494
| New | +$2.17M |
|
924
Deckers Outdoor
DECK
$10.6B
| $2.12M | 0.01% |
24,078
-17,334
| -42% | -$1.39M |
|
925
Prothena Corp
PRTA
$423M
| $2.11M | 0.01% |
30,856
+29,850
| +2,967% | +$1.93M |
|
Similar funds
Federated Hermes's Q2 2023 Portfolio in Review
As of Q2 2023, Federated Hermes held 2,279 positions worth $40.3B, up 1.3% from $39.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2023 filing shows 170 new, 711 increased, 1,071 reduced and 189 closed positions. Its largest new stake was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M. The largest sale was Clorox, an estimated $229M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q2 2023 buy was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M.
- Federated Hermes added most to Amgen in Q2 2023, an estimated $178M increase.
- Federated Hermes's biggest Q2 2023 reduction was Clorox, cutting an estimated $229M.
- Federated Hermes fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $55.4M.
- Federated Hermes's ten largest holdings make up 16% of its $40.3B portfolio in Q2 2023.
- Federated Hermes opened 170 new positions and closed 189 in Q2 2023.
- Federated Hermes's portfolio value rose 1.3% quarter-over-quarter to $40.3B.
Based on Federated Hermes's 13F filing for Q2 2023, filed 14 Aug 2023.